Short Interest in Ocean Biomedical, Inc. (NASDAQ:OCEAW) Decreases By 52.8%

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a large drop in short interest in February. As of February 15th, there was short interest totalling 15,100 shares, a drop of 52.8% from the January 31st total of 32,000 shares. Based on an average daily volume of 70,200 shares, the days-to-cover ratio is presently 0.2 days.

Ocean Biomedical Trading Down 1.5 %

Ocean Biomedical stock traded down $0.00 during mid-day trading on Monday, reaching $0.03. The company had a trading volume of 2,076 shares, compared to its average volume of 97,674. The stock’s 50-day simple moving average is $0.03 and its 200-day simple moving average is $0.04. Ocean Biomedical has a 1 year low of $0.02 and a 1 year high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.